2008
DOI: 10.2741/2875
|View full text |Cite
|
Sign up to set email alerts
|

Pathogenic role of CCL2/MCP-1 in scleroderma

Abstract: Scleroderma is a connective tissue disease with unknown etiology characterized by excessive deposition of extracellular matrix in the skin. Cellular infiltrates of certain immune cells and proinflammatory mediators are suggested to play a crucial role in cutaneous fibrosis, forming complicated networks between fibroblasts and immune cells via cell-cell communications. Tissue-selective trafficking of leukocytes is mediated by combinations of adhesion molecules and chemokines. Recent studies have shown that an i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
11
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(12 citation statements)
references
References 95 publications
1
11
0
Order By: Relevance
“…Many studies have emphasized the pathogenic role of MCP-1 (CCL2)/CCR2 axis in the induction of fibrosis, scleroderma, liver cirrhosis, atherosclerosis, pulmonary fibrosis, renal fibrosis, and colon fibrosis in human and animal models. [61][62][63][64][65] Utilizing a murine dermal fibrosis model induced by a subcutaneous injection of bleomycin into the dorsal skin of MCP-1 knockout mice, diminished induction of skin fibrosis was found in mice, suggesting that MCP-1 as a key determinant in the development of skin fibrosis was induced by bleomycin in vivo. 66 Mechanical force significantly modulates both T-celldependent inflammation and scar formation in another murine HTS model, in which as Th2 chemokine, MCP-1 signaling was involved.…”
Section: 29mentioning
confidence: 99%
“…Many studies have emphasized the pathogenic role of MCP-1 (CCL2)/CCR2 axis in the induction of fibrosis, scleroderma, liver cirrhosis, atherosclerosis, pulmonary fibrosis, renal fibrosis, and colon fibrosis in human and animal models. [61][62][63][64][65] Utilizing a murine dermal fibrosis model induced by a subcutaneous injection of bleomycin into the dorsal skin of MCP-1 knockout mice, diminished induction of skin fibrosis was found in mice, suggesting that MCP-1 as a key determinant in the development of skin fibrosis was induced by bleomycin in vivo. 66 Mechanical force significantly modulates both T-celldependent inflammation and scar formation in another murine HTS model, in which as Th2 chemokine, MCP-1 signaling was involved.…”
Section: 29mentioning
confidence: 99%
“…1d,e). Notably, concentrations of MCP-1, a chemokine highly associated with inflammatory cell recruitment and fibrotic skin diseases 35,2022 , were also less in FAK knockout wounds than in wild-type wounds (densitometry: 0.4 ± 0.05 for FAK knockout compared to 0.6 ± 0.07 for wild type (means ± s.e.m. ), P < 0.05) (Fig.…”
mentioning
confidence: 99%
“…In early-stage SSc, CCR2-positive fibroblasts show overexpression of α-SMA, CTGF and CCL2 [43], suggesting a potential autocrine regulation via the CCL2/CCR2 loop in SSc. The CCL2/CCR2 pathway contributes to the pathogenesis of dermal sclerosis [43], and inhibition of this signaling pathway by antagonists against CCR2 is currently under strategy for SSc in clinical trials [44].…”
Section: Ccl2/mcp-1mentioning
confidence: 99%